Dyne Therapeutics's total assets for Q1 2026 were $1.08B, a decrease of -9.02% from the previous quarter. DYN total liabilities were $214.90M for the fiscal quarter, a 0.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.